| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $858K | +43.0% |
| R&D Expense | $19.6M | -52.8% |
| SG&A Expense | $14.3M | -27.0% |
| Operating Income | -$33.1M | +45.3% |
| Pre-tax Income | -$9.0M | +83.8% |
| Income Tax | $0 | — |
| Net Income | -$9.0M | +84.5% |
| EPS (Basic) | -$1.59 | -19.5% |
| EPS (Diluted) | -$1.59 | -19.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $31.4M | +125.7% |
| Short-term Investments | $23.4M | -54.7% |
| Current Assets | $61.3M | -9.7% |
| Total Assets | $62.3M | -8.6% |
| Current Liabilities | $4.2M | -32.3% |
| Total Liabilities | $4.3M | -33.3% |
| Stockholders' Equity | $58.0M | -6.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$29.8M | +39.5% |
| Investing Cash Flow | $47.3M | +41.1% |
| Financing Cash Flow | $16K | -99.7% |